Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA Statement on 340B PAUSE Act

December 21, 2017

The legislation introduced today by Representatives Larry Bucshon and Scott Peters is yet another important action taken this year to begin to address the problems in the 340B program.

Read More

PhRMA Announces Major Commitment to Address the Opioid Crisis in America

December 12, 2017

PhRMA announced a new multi-year, multimillion dollar initiative to address the opioid crisis, which will include a partnership with the Addiction Policy Forum to fund state and local programs, as well as support for new public policies that help families and individuals impacted by the crisis.

Read More

PhRMA Challenges Unconstitutional Provisions of California’s SB 17 in Federal Court

December 8, 2017

Today, PhRMA initiated litigation in the United States District Court for the Eastern District of California challenging SB 17, an unprecedented and unconstitutional California law.

Read More

New Report Shows How Supply Chain Shapes Brand-Name Medicine Prices

November 29, 2017

A new report from PhRMA is among the first to examine how money flows through the supply chain system – which includes wholesalers, pharmacy benefit managers (PBMs), pharmacies and insurers – and how that impacts what patients pay at the pharmacy.

Read More

PhRMA Statement on Report President Commissions’ Final Report with Opioid Recommendations

November 2, 2017

PhRMA is working with the (NIH) and NIDA to establish a public-private partnership that will advance the development of non-addictive pain treatment options.

Read More

Leading Biopharmaceutical Researchers to Showcase the New Era of Medicine on Capitol Hill

November 2, 2017

PhRMA is bringing more than 50 scientists and researchers from America’s biopharmaceutical companies to meet with policymakers and senior staff today on Capitol Hill.

Read More

PhRMA Statement on House Vote to Repeal IPAB

November 2, 2017

PhRMA applauds the House for taking much needed action to repeal the Independent Payment Advisory Board (IPAB). This Board of unelected bureaucrats was given virtually unchecked power to make decisions that impact more than 55 million Medicare beneficiaries – overruling Congress’ authority over the Medicare program and threatening patient access to needed medicines.

Read More

Biopharmaceutical Leaders: Japanese Patients, Health Care System and Economy Benefit from Access to Innovative Medicines

November 1, 2017

Leaders from US -based innovative biopharmaceutical companies met with Japanese government officials and other stakeholders October 30-November 1 to underscore the importance of the country’s critical role as a pro-innovation economy.

Read More

PhRMA Statement on Trump Opioids Announcement

October 26, 2017

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement.

Read More

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

October 23, 2017

On behalf of our members, PhRMA wants to thank you for your leadership in the recovery efforts in Puerto Rico after two recent hurricanes – most notably Hurricane Maria – struck the island last month.

Read More